MICHAEL BUKOSKY was appointed chief operating officer of USMD Holdings Inc., and will oversee daily operations of therapeutic, diagnostic and centralized services, including hospital services, cancer treatment centers, clinical and pathology labs, imaging, human resources, contracting, revenue cycle, marketing and communications and IT. Bukosky will retain his position as president of USMD Physician Practice Management,...
A group of melanoma experts, joined by three advocacy groups focused on melanoma, has engaged FDA in a public discussion of the challenges of developing new drugs in the refractory setting and the role crossover can play in such trials.
